ID

42822

Descripción

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Palabras clave

  1. 5/3/15 5/3/15 -
  2. 9/3/15 9/3/15 -
  3. 23/4/15 23/4/15 -
  4. 15/12/15 15/12/15 -
  5. 17/9/21 17/9/21 -
Subido en

17 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Adverse Event AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Adverse Event
Descripción

Adverse Event

Point in time
Descripción

Point in time

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1276413
UMLS CUI [1,2]
C2348792
If Maintenance: Month
Descripción

Maintenance Month

Tipo de datos

integer

Alias
UMLS CUI-1
C0481504
UMLS CUI-2
C0439231
Description of Adverse Event
Descripción

Description of Adverse Event

Tipo de datos

text

Alias
UMLS CUI [1]
C0877248
Adverse Event Term
Descripción

Adverse Event Term

Tipo de datos

text

Alias
UMLS CUI-1
C2826934
Serious Adverse Event
Descripción

Serious Adverse Event

Tipo de datos

boolean

Alias
UMLS CUI-1
C1519255
Grade of Adverse Event
Descripción

Grade of Adverse Event

Tipo de datos

integer

Alias
UMLS CUI-1
C2985911
Outcome
Descripción

Outcome

Tipo de datos

integer

Alias
UMLS CUI-1
C1705586
Treatment/Action taken
Descripción

Treatment/Action taken

Tipo de datos

text

Alias
UMLS CUI-1
C0087111
Adverse Event Start Date
Descripción

Adverse Event Start Date

Tipo de datos

date

Alias
UMLS CUI-1
C2697888
Adverse Event End Date
Descripción

Adverse Event End Date

Tipo de datos

date

Alias
UMLS CUI-1
C2697886
Adverse Event related to
Descripción

Adverse Event related to

Cytarabine
Descripción

Cytarabine

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0010711
Daunorubicin
Descripción

Daunorubicin

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0011015
Dasatinib
Descripción

Dasatinib

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C1455147
Underlying Disease
Descripción

Underlying Disease

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0277554
Concomitant medication
Descripción

Concomitant medication

Tipo de datos

integer

Alias
UMLS CUI [1]
C2347852
Other
Descripción

Other

Tipo de datos

integer

Alias
UMLS CUI [1]
C0205394
Signature
Descripción

Signature

Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Descripción

Name of Investigator

Tipo de datos

text

Alias
UMLS CUI-1
C0008961
Signature of investigator
Descripción

Signature of investigator

Tipo de datos

text

Alias
UMLS CUI-1
C2346576

Similar models

Adverse Event AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Adverse Event
Item
Point in time
integer
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Code List
Point in time
CL Item
Diagnostic (0)
C0086143 (UMLS CUI-1)
CL Item
Induction I (1)
C3179010 (UMLS CUI-1)
CL Item
Induction II (optional) (2)
C3179010 (UMLS CUI-1)
CL Item
Consolid. I (3)
C3179017 (UMLS CUI-1)
CL Item
Consolid. II (4)
C3179017 (UMLS CUI-1)
CL Item
Consolid. III (5)
C3179017 (UMLS CUI-1)
CL Item
Consolid. IV (6)
C3179017 (UMLS CUI-1)
CL Item
Maintenance (7)
C0481504 (UMLS CUI-1)
Item
If Maintenance: Month
integer
C0481504 (UMLS CUI-1)
C0439231 (UMLS CUI-2)
Code List
If Maintenance: Month
CL Item
after 1 Month (1)
C0439231 (UMLS CUI-1)
C0205447 (UMLS CUI-2)
CL Item
after 2 Months (2)
C0439231 (UMLS CUI-1)
C0205448 (UMLS CUI-2)
CL Item
after 3 Months (3)
C0439231 (UMLS CUI-1)
C0205449 (UMLS CUI-2)
CL Item
after 4 Months (4)
C0439231 (UMLS CUI-1)
C0205450 (UMLS CUI-2)
CL Item
after 5 Months (5)
C0439231 (UMLS CUI-1)
C0205451 (UMLS CUI-2)
CL Item
after 6 Months (6)
C0439231 (UMLS CUI-1)
C0205452 (UMLS CUI-2)
CL Item
after 7 Months (7)
C0439231 (UMLS CUI-1)
C0205453 (UMLS CUI-2)
CL Item
after 8 Months (8)
C0439231 (UMLS CUI-1)
C0205454 (UMLS CUI-2)
CL Item
after 9Months (9)
C0439231 (UMLS CUI-1)
C0205455 (UMLS CUI-2)
CL Item
after 10 Months (10)
C0439231 (UMLS CUI-1)
C0205456 (UMLS CUI-2)
CL Item
after 11 Months (11)
C0439231 (UMLS CUI-1)
C0205457 (UMLS CUI-2)
CL Item
after 12 Months (12)
C0439231 (UMLS CUI-1)
C0205458 (UMLS CUI-2)
Description of Adverse Event
Item
Description of Adverse Event
text
C0877248 (UMLS CUI [1])
Adverse Event Term
Item
Adverse Event Term
text
C2826934 (UMLS CUI-1)
Serious Adverse Event
Item
Serious Adverse Event
boolean
C1519255 (UMLS CUI-1)
Item
Grade of Adverse Event
integer
C2985911 (UMLS CUI-1)
Code List
Grade of Adverse Event
CL Item
Mild  (1)
C2945599 (UMLS CUI-1)
CL Item
Moderate (2)
C0205081 (UMLS CUI-1)
CL Item
Severe (3)
C0205082 (UMLS CUI-1)
CL Item
Life-Threatening (4)
C2826244 (UMLS CUI-1)
CL Item
Death related to AE (5)
C0877248 (UMLS CUI-1)
C0011065 (UMLS CUI-2)
Item
Outcome
integer
C1705586 (UMLS CUI-1)
Code List
Outcome
CL Item
recovered (1)
C2826210 (UMLS CUI-1)
CL Item
not yet recovered (2)
C1709277 (UMLS CUI-1)
CL Item
recovered with sequelae (3)
C1709862 (UMLS CUI-1)
CL Item
Death (4)
C0011065 (UMLS CUI-1)
CL Item
unknown (5)
C0439673 (UMLS CUI-1)
Treatment/Action taken
Item
Treatment/Action taken
text
C0087111 (UMLS CUI-1)
Adverse Event Start Date
Item
Adverse Event Start Date
date
C2697888 (UMLS CUI-1)
Adverse Event End Date
Item
Adverse Event End Date
date
C2697886 (UMLS CUI-1)
Item Group
Adverse Event related to
Item
Cytarabine
integer
C0877248 (UMLS CUI [1,1])
C0010711 (UMLS CUI [1,2])
Code List
Cytarabine
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Daunorubicin
integer
C0877248 (UMLS CUI [1,1])
C0011015 (UMLS CUI [1,2])
Code List
Daunorubicin
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Dasatinib
integer
C0877248 (UMLS CUI [1,1])
C1455147 (UMLS CUI [1,2])
Code List
Dasatinib
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Underlying Disease
integer
C0877248 (UMLS CUI [1,1])
C0277554 (UMLS CUI [1,2])
Code List
Underlying Disease
CL Item
recovered (1)
C2826210 (UMLS CUI-1)
CL Item
not yet recovered (2)
C1709277 (UMLS CUI-1)
CL Item
recovered with sequelae (3)
C1709862 (UMLS CUI-1)
CL Item
Death (4)
C0011065 (UMLS CUI-1)
CL Item
unknown (5)
C0439673 (UMLS CUI-1)
Item
Concomitant medication
integer
C2347852 (UMLS CUI [1])
Code List
Concomitant medication
CL Item
definitely (1)
C1704787 (UMLS CUI-1)
CL Item
probably (2)
C0750492 (UMLS CUI-1)
CL Item
possible (3)
C0332149 (UMLS CUI-1)
CL Item
unlikely (4)
C0750558 (UMLS CUI-1)
CL Item
not related (5)
C1546988 (UMLS CUI-1)
CL Item
Medication not administered (6)
C0445106 (UMLS CUI-1)
C0806914 (UMLS CUI-2)
Item
Other
integer
C0205394 (UMLS CUI [1])
Code List
Other
CL Item
recovered (1)
C2826210 (UMLS CUI-1)
CL Item
not yet recovered (2)
C1709277 (UMLS CUI-1)
CL Item
recovered with sequelae (3)
C1709862 (UMLS CUI-1)
CL Item
Death (4)
C0011065 (UMLS CUI-1)
CL Item
unknown (5)
C0439673 (UMLS CUI-1)
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial